Hong Kong

Hong Kong

  • July 10, 2017
  • Comment: 0

Hospital Authority, Hong Kong

 

Quality improvement sharing

 

Category: Quality of care and patient safety

 
Learning objectives
 
In this session, three experts will share their experience in quality improvement and patient safety programs ranging from surgical outcome improvement to infection control programs. The audience will be able to learn from their experience on how to conduct practical large-scale quality and safety programs as well as the success factors when conducting such programs. The importance of engaging front-line clinical staff and sharing of good practices will also be discussed.
 
 
Summary of the session
 
In this session, three speakers from Hong Kong will share their experiences in three quality improvement and patient safety programs.
The Surgical Outcome Monitoring and Improvement Program (SOMIP) was introduced in Hong Kong public hospitals since 2008. It is a program where the outcomes of major and ultra-major surgeries were being monitored using a risk adjusted model. It helped to identify hospitals that showed statistically significant better or worse outcomes in terms of mortality and mortality in emergency and elective operations. Factors that may affect outcomes were analyzed in order to identify areas where improvement could be made. A general trend of improvement in mortality and morbidity of specific operations and overall improvement of emergency operations were observed.
The Antibiotics Stewardship Program was implemented in public hospitals of Hong Kong in 2005. In this program, various strategies were adopted to contain the development of Antimicrobial Resistance and to reduce the incidence of the antibiotics related adverse effects. From 2005 to 2016 the consumption of targeted broad spectrum antibiotics has increased by 125% whereas the usage of intravenous Fluoroquinolones has dropped by 7%. The total consumption of all antibiotics also increases by 22%. The incidence of MRSA remained steady whereas the incidence of VRE, MDRA and MRPA has dropped in recent few years.
The program has been shown to be effective in reducing antibiotics related adverse effects and hospital acquired Clostridium difficile infections. It is also one of the major strategies to contain the development of antimicrobial resistance.
A Targeted Screening on Admission (TSA) for occult asymptomatic Vancomycin Resistant Enterococci (VRE) gut carriers was conducted in public hospitals in Hong Kong during a 10-wek period from November 2013 to January 2014. During the 10-week screening, patients who had history of hospitalization to other hospitals in recent 3 months were screened upon admission with a total of 205 occult cases identified. A total of 19,351 specimens from 14,516 patients who fulfilled the screening criteria were collected with a positive rate of 1.4% (205/14,516).
 
 
Moderator
 
Dr. Tony Pat-sing Ko
Cluster Chief Executive
Hospital Authority, Hong Kong
 
 
 
 
 
 
 
Speakers
 
Dr. Heng-tat Leong
Chief of service (Surgery)
Hospital Authority, Hong Kong
 
Presentation: Promoting prudent use of antibiotics through antibiotic stewardship
Objectives: To optimize the usage of antibiotics in public hospitals in HK to contain the development of antimicrobial resistance, to reduce the incidence of antibiotics related adverse effects and to reduce hospital acquired infections including Clostridium difficile infections.
 
 
 
Dr. Kin Wing Choi
Consultant
Hospital Authority, Hong Kong
 
Presentation: Promoting prudent use of antibiotics through antibiotic stewardship
Objectives: To optimize the usage of antibiotics in public hospitals in HK to contain the development of antimicrobial resistance, to reduce the incidence of antibiotics related adverse effects and to reduce hospital acquired infections including Clostridium difficile infections.
 
 
 
 
Ka Lam Cheng
Advanced Practice Nurse
Hospital Authority, Hong Kong
 
Presentation: Enhancing infection control through surveillance and investigation
Objectives: The screening exercise aimed at unraveling occult asymptomatic VRE gut carriers to prevent the spread of VRE, and collate further epidemiological data to direct long term control strategy of VRE.
 
 
 

Event Timeslots (1)

South
-
HOSPITAL AUTHORITY
Quality improvement sharing